Related Experiment Video
Updated: Jul 11, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Anthrax vaccine and public health policy
Martin Meyer Weiss1, Peter D Weiss, Joseph B Weiss
1Veterans Administration, Sepulveda, Calif 91343, USA. martin.weiss@med.va.gov
Abstract:
The Centers for Disease Control and Prevention has classified Bacillus anthracis, the causative organism of anthrax, as a category A potential bioterrorism agent. There are critical shortcomings in the US anthrax vaccine program. Rather than depending on the private sector, the government must assume direct production of anthrax vaccine. The development of a capacity capable of preemptive immunization of the public against anthrax should be considered.
Related Concept Videos
Inhalation Anthrax
Smallpox
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines
Microorganisms in Medicine and Therapeutics

